At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02396 B&K CORP-B
Market Closed 09-25 14:13:25
4.365
-0.020
-0.46%
High4.370
Low4.365
Vol1.20K
Open4.370
D1 Closing4.385
Amplitude0.11%
Mkt Cap513.58M
Tradable Cap362.39M
Total Shares117.66M
T/O5.24K
T/O Rate0.00%
Tradable Shares83.02M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
B&K Corp. 2026 Interim: Wider RMB121.92 Million Loss as R&D Spend Jumps 58.8%; Core Burn & DFU Therapies Advance
B&K Corp Ltd is a China-based company principally engaged in the research and development of biopharmaceutical products. The Company committed to developing therapies with an emphasis on protein drugs for indications with medical needs and market opportunities. The Company primarily focus on the discovery, development and commercialization of therapies for wound healing, currently platelet-derived growth factor (PDGF) drugs. The Company mainly operates its businesses in the domestic market.